Beijing Foyou Pharma (601089.SH): Montmorillonite powder obtained drug registration certificate.

Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. ("Zhejiang Aisheng") recently received the "Drug Registration Certificate" for montmorillonite powder (specification: 3g of montmorillonite per bag) issued by the National Medical Products Administration. Montmorillonite powder was developed by IPSEN PHARMA and was first approved for market in France. The original research-oriented product was approved for market in 2000, under the brand name Smecta, used for adult acute and chronic diarrhea, and children's acute diarrhea.